|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.780 USD | -5.03% |
|
-6.67% | -30.87% |
| 13/05 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 13/05 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Company Valuation: Bolt Biotherapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 182.7 | 48.96 | 42.52 | 20.48 | 10.5 | 7.264 | - | - |
| Change | - | -73.2% | -13.15% | -51.84% | -48.75% | -30.79% | - | - |
| Enterprise Value (EV) | -3.524 | -97.32 | -39.45 | 20.48 | 10.5 | 7.264 | 7.264 | 7.264 |
| Change | - | -2,661.37% | 59.46% | 151.92% | -48.75% | -30.79% | 0% | 0% |
| P/E | -1.65x | -0.55x | -0.61x | -0.32x | -0.31x | -0.02x | -0.01x | -0.01x |
| PBR | 0.73x | 0.29x | 0.38x | - | - | - | - | - |
| PEG | - | 0x | 0x | 0.03x | 0x | -0x | -0x | -0x |
| Capitalization / Revenue | 145x | 8.55x | 5.4x | 2.66x | 1.36x | 4.81x | 2.08x | 0.91x |
| EV / Revenue | -0x | -0x | -0x | 0x | 0x | 4.81x | 2.08x | 0.91x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | -0x | -0x | -0.16x | -0.15x | -0.12x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -59.4 | -47.2 | -36.6 | -33 | -17.85 | -238.3 | -255 | -616.8 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1.26 | 5.729 | 7.876 | 7.69 | 7.695 | 1.509 | 3.5 | 8 |
| EBITDA | -83.1 | -79.08 | -65.12 | - | - | - | - | - |
| EBIT 1 | -92.79 | -90.32 | -76.2 | -73.05 | -36.11 | -45.15 | -47.5 | -60 |
| Net income 1 | -98.59 | -88.1 | -69.2 | -63.12 | -33.38 | -44.52 | -47.5 | -60 |
| Net Debt | -186.2 | -146.3 | -81.97 | - | - | - | - | - |
| Reference price 2 | 98.000 | 26.000 | 22.400 | 10.702 | 5.468 | 3.780 | 3.780 | 3.780 |
| Nbr of stocks (in thousands) | 1,864 | 1,883 | 1,898 | 1,914 | 1,919 | 1,922 | - | - |
| Announcement Date | 30/03/22 | 29/03/23 | 21/03/24 | 24/03/25 | 12/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.02x | - | - | - | 72.64L | |
| 20.57x | 6.33x | 13.8x | 1.56% | 5.49TCr | |
| 32.72x | 8.29x | 25.68x | 0.06% | 5.46TCr | |
| -44.31x | 14.51x | -42.32x | -.--% | 2.51TCr | |
| -18.2x | 4.33x | -7.58x | -.--% | 2.31TCr | |
| 25x | 4.9x | 12.9x | -.--% | 1.99TCr | |
| 24.48x | 4.79x | 15.58x | -.--% | 1.75TCr | |
| 49.34x | 20.07x | 51.69x | 0.07% | 1.65TCr | |
| -539.24x | 37.99x | -4235.53x | -.--% | 1.57TCr | |
| 17.75x | 5.16x | 12.01x | -.--% | 1.42TCr | |
| Average | -43.19x | 11.82x | -461.53x | 0.19% | 2.42TCr | |
| Weighted average by Cap. | -21.17x | 10.13x | -265.84x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BOLT Stock
- Valuation Bolt Biotherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition